Parainfluenza Virus Type 3 Infections in Hematopoetic Stem Cell Transplant Recipients: Response to Ribavirin Therapy
- 1 December 2000
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (6), 1516-1518
- https://doi.org/10.1086/317482
Abstract
Parainfluenza virus (PIV) infection can be a problem among hematopoetic stem cell transplant recipients. 125 patients were prospectively evaluated for respiratory viral infections.We describe 5 patients with PIV 3 infection and their response to early treatment with ribavirin.Keywords
This publication has 6 references indexed in Scilit:
- Ribavirin polarizes human T cell responses towards a Type 1 cytokine profileJournal of Hepatology, 1999
- Epidemiological features of parainfluenza virus infections: Laboratory surveillance in England and Wales, 1975–1997European Journal of Epidemiology, 1999
- Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infectionsBone Marrow Transplantation, 1997
- Respiratory Disease Due to Parainfluenza Virus in Adult Bone Marrow Transplant RecipientsClinical Infectious Diseases, 1996
- RECOVERY FROM ADENOVIRUS PNEUMONIA IN A SEVERE COMBINED IMMUNODEFICIENCY PATIENT TREATED WITH INTRAVENOUS RIBAVIRINTransplantation, 1995
- Parainfluenza Virus Respiratory Infection after Bone Marrow TransplantationNew England Journal of Medicine, 1992